DK1073754T3 - Fremgangsmåde til fremstilling af proteinmutanter med lille allergen reaktion hos mennesker - Google Patents
Fremgangsmåde til fremstilling af proteinmutanter med lille allergen reaktion hos menneskerInfo
- Publication number
- DK1073754T3 DK1073754T3 DK99918575T DK99918575T DK1073754T3 DK 1073754 T3 DK1073754 T3 DK 1073754T3 DK 99918575 T DK99918575 T DK 99918575T DK 99918575 T DK99918575 T DK 99918575T DK 1073754 T3 DK1073754 T3 DK 1073754T3
- Authority
- DK
- Denmark
- Prior art keywords
- humans
- preparation
- small
- allergenic protein
- protein mutants
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6878—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids in eptitope analysis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/52—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea
- C12N9/54—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea bacteria being Bacillus
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
- G01N33/5047—Cells of the immune system
- G01N33/505—Cells of the immune system involving T-cells
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/060,872 US6835550B1 (en) | 1998-04-15 | 1998-04-15 | Mutant proteins having lower allergenic response in humans and methods for constructing, identifying and producing such proteins |
EP99918575A EP1073754B9 (en) | 1998-04-15 | 1999-04-14 | Process for the preparation of protein mutants having lower allergenic response in humans. |
PCT/US1999/008253 WO1999053038A2 (en) | 1998-04-15 | 1999-04-14 | Mutant proteins having lower allergenic response in humans and methods for constructing, identifying and producing such proteins |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1073754T3 true DK1073754T3 (da) | 2005-05-09 |
Family
ID=22032273
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK99918575T DK1073754T3 (da) | 1998-04-15 | 1999-04-14 | Fremgangsmåde til fremstilling af proteinmutanter med lille allergen reaktion hos mennesker |
DK08009499.8T DK1997897T3 (da) | 1998-04-15 | 1999-04-14 | Mutantproteiner med lavere allergenisk respons hos mennesker og fremgangsmåder til konstruktion, identifikation og fremstilling af sådanne proteiner |
DK04016880.9T DK1586649T3 (da) | 1998-04-15 | 1999-04-14 | Mutantproteiner med lav allergen reaktion hos mennesker og fremgangsmåder til konstruktion, identificering og fremstilling af sådanne proteiner |
Family Applications After (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK08009499.8T DK1997897T3 (da) | 1998-04-15 | 1999-04-14 | Mutantproteiner med lavere allergenisk respons hos mennesker og fremgangsmåder til konstruktion, identifikation og fremstilling af sådanne proteiner |
DK04016880.9T DK1586649T3 (da) | 1998-04-15 | 1999-04-14 | Mutantproteiner med lav allergen reaktion hos mennesker og fremgangsmåder til konstruktion, identificering og fremstilling af sådanne proteiner |
Country Status (20)
Country | Link |
---|---|
US (4) | US6835550B1 (da) |
EP (3) | EP1997897B1 (da) |
JP (1) | JP4447774B2 (da) |
KR (1) | KR20010034776A (da) |
CN (1) | CN1302113C (da) |
AT (2) | ATE452195T1 (da) |
AU (1) | AU752934B2 (da) |
BR (1) | BR9909640A (da) |
CA (1) | CA2327311C (da) |
CZ (1) | CZ20003789A3 (da) |
DE (3) | DE69941827D1 (da) |
DK (3) | DK1073754T3 (da) |
ES (2) | ES2229703T4 (da) |
ID (1) | ID26645A (da) |
IL (2) | IL138445A0 (da) |
MX (2) | MXPA05003288A (da) |
NO (1) | NO20005153L (da) |
NZ (2) | NZ524596A (da) |
PL (1) | PL343509A1 (da) |
WO (1) | WO1999053038A2 (da) |
Families Citing this family (106)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6750329B1 (en) * | 1989-05-05 | 2004-06-15 | Research Development Foundation | Antibody delivery system for biological response modifiers |
US20050209121A1 (en) * | 1990-12-05 | 2005-09-22 | Novozymes A/S | Proteins with changed epitopes and methods for the production thereof |
US6967080B1 (en) * | 1990-12-05 | 2005-11-22 | Novozymes A/S | Proteins with changed epitopes and methods for the production thereof |
MA23346A1 (fr) * | 1993-10-14 | 1995-04-01 | Genencor Int | Variantes de la subtilisine |
US6936249B1 (en) | 1998-04-15 | 2005-08-30 | Genencor International, Inc. | Proteins producing an altered immunogenic response and methods of making and using the same |
US6642011B2 (en) * | 1998-04-15 | 2003-11-04 | Genencor International, Inc. | Human protease and use of such protease for pharmaceutical applications and for reducing the allergenicity of non-human proteins |
US6835550B1 (en) * | 1998-04-15 | 2004-12-28 | Genencor International, Inc. | Mutant proteins having lower allergenic response in humans and methods for constructing, identifying and producing such proteins |
US6838269B1 (en) * | 1998-04-15 | 2005-01-04 | Genencor International, Inc. | Proteins producing an altered immunogenic response and methods of making and using the same |
CA2249648A1 (en) * | 1998-11-04 | 2000-05-04 | Nabil G. Seidah | Mammalian subtilisin/kexin isozyme ski-1: a proprotein convertase with a unique cleavage specificity |
US6946128B1 (en) * | 1999-07-22 | 2005-09-20 | The Procter & Gamble Company | Protease conjugates having sterically protected epitope regions |
CZ2002212A3 (cs) * | 1999-07-22 | 2002-07-17 | The Procter & Gamble Company | Varianty subtilisinové proteasy mající aminokyselinové substituce v definovaných epitopových oblastech |
WO2001007575A2 (en) * | 1999-07-22 | 2001-02-01 | The Procter & Gamble Company | Subtilisin protease variants having amino acid deletions and substitutions in defined epitope regions |
WO2001040281A2 (en) * | 1999-12-02 | 2001-06-07 | Thromb-X N.V. | Method for reducing the immunogenicity of heterologous proteins by elimination of t-cell epitopes |
WO2001041786A1 (en) | 1999-12-10 | 2001-06-14 | The General Hospital Corporation | METHODS TO STIMULATE INSULIN PRODUCTION BY PANCREATIC β-CELLS |
US6960462B2 (en) | 2000-02-08 | 2005-11-01 | Dsm Ip Assets B.V | Use of acid-stable subtilisin proteases in animal feed |
MX261332B (es) * | 2000-02-08 | 2008-10-14 | Hoffmann La Roche | Uso de proteasas estables en acido para alimento de animales. |
US6855548B2 (en) | 2000-02-08 | 2005-02-15 | F. Hoffman-La Roche Ag | Use of acid-stable proteases in animal feed |
US20020192792A1 (en) * | 2000-04-28 | 2002-12-19 | Palle Schneider | Laccase mutants |
US6673580B2 (en) * | 2000-10-27 | 2004-01-06 | Genentech, Inc. | Identification and modification of immunodominant epitopes in polypeptides |
HUP0402071A2 (hu) * | 2001-02-06 | 2005-01-28 | Merck Patent Gmbh. | Csökkentett immunogenitású, módosított leptin |
ZA200305980B (en) * | 2001-02-12 | 2007-01-31 | Res Dev Foundation | Modified proteins, designer toxins, and methods of making thereof |
EP1239032A1 (en) * | 2001-03-02 | 2002-09-11 | Société des Produits Nestlé S.A. | Lactic acid bacteria as agents for treating and preventing allergy |
CN100489094C (zh) * | 2001-03-23 | 2009-05-20 | 金克克国际有限公司 | 具有改变的免疫原性反应的蛋白质及制备和使用该蛋白质的方法 |
WO2002096454A1 (en) * | 2001-05-31 | 2002-12-05 | D. Collen Research Foundation Vzw | Recombinant molecules with reduced immunogenicity, methods and intermediates for obtaining them and their use in pharmaceutical compositions and diagnostic tools |
WO2002098454A2 (en) * | 2001-05-31 | 2002-12-12 | D. Collen Research Foundation Vzw Onderwijsen Navorsing Campus Gasthuisberg K.U. Leuven | Recombinant molecules with reduced immunogenicity, methods and intermediates for obtaining them and their use in pharmaceutical compositions and diagnostic tools |
JP2004535202A (ja) | 2001-07-17 | 2004-11-25 | リサーチ ディベロップメント ファンデーション | アポトーシス促進性蛋白質を含む治療剤 |
US7157416B2 (en) * | 2001-07-20 | 2007-01-02 | Genencor International, Inc. | Stabilization of enzymes |
MXPA04004417A (es) * | 2001-11-12 | 2004-08-11 | Merck Patent Gmbh | Anticuerpo anti-tnf alfa modificado. |
US20040209312A1 (en) * | 2001-11-13 | 2004-10-21 | Harding Fiona A | Identifying and reducing the allergenicity of food proteins |
AU2002353178C1 (en) * | 2001-12-31 | 2011-02-03 | Genencor International, Inc. | Proteases producing an altered immunological response and methods of making and using the same |
CA2476890C (en) * | 2002-02-26 | 2013-07-16 | Genencor International, Inc. | Subtilisin carlsberg proteins with reduced immunogenicity |
NZ534198A (en) * | 2002-02-26 | 2005-11-25 | Genencor Int | Population based assessments and means to rank the relative immunogenicity of proteins |
EP2339017A3 (en) | 2002-03-29 | 2011-10-12 | Genencor International, Inc. | Enhanced protein expression in bacillus |
JP2005538694A (ja) * | 2002-04-18 | 2005-12-22 | メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフトング | 修飾されたviii因子 |
DK1578772T3 (da) * | 2002-05-01 | 2010-08-16 | Danisco Us Inc | Cytokiner og cytokinreceptorer med reduceret immunogenicitet |
JP2006506964A (ja) * | 2002-06-12 | 2006-03-02 | リサーチ ディベロップメント ファンデーション | 治療剤としての免疫毒素及びその利用 |
US20060228791A1 (en) * | 2002-06-26 | 2006-10-12 | Novozymes A/S | Subtilases and subtilase variants having altered immunogenicity |
US20040007251A1 (en) * | 2002-07-10 | 2004-01-15 | Kimberly-Clark Worldwide, Inc. | Cleaners for the control and removal of allergens |
US7566448B2 (en) * | 2002-07-30 | 2009-07-28 | Genencor International, Inc. | Reduced aerosol generating formulations |
WO2004014938A2 (en) * | 2002-08-09 | 2004-02-19 | Xencor | Thrombopoiesis-stimulating proteins having reduced immunogenicity |
BRPI0407294B1 (pt) | 2003-02-07 | 2017-06-13 | Novozymes A/S | Use of a protease of the peptidases family s2a and / or peptidasis fmilia s1e, method for producing polipeptide, animal feed additive, animal feed composition, and, detergent composition |
WO2004078960A1 (en) | 2003-02-26 | 2004-09-16 | Genencor International, Inc. | Amylases producing an altered immunogenic response and methods of making and using the same |
EP2500423B1 (en) | 2003-02-26 | 2015-06-17 | Danisco US Inc. | Amylases producing an altered immunogenic response and methods of making and using the same |
WO2005051975A2 (en) * | 2003-07-03 | 2005-06-09 | Avatar Biotechnologies, Inc. | Methods for obtaining molecules with reduced immunogenicity |
ES2358092T3 (es) | 2003-10-10 | 2011-05-05 | Novozymes A/S | Variantes de proteasa. |
ATE552276T1 (de) | 2003-11-01 | 2012-04-15 | Merck Patent Gmbh | Modifizierter anti-cd52-antikörper |
WO2005095592A2 (en) * | 2004-04-02 | 2005-10-13 | Novozymes A/S | Subtilase variants having altered immunogenicity |
JP2007532114A (ja) * | 2004-04-09 | 2007-11-15 | ジェネンコー・インターナショナル・インク | バチルスにおけるpckA修飾および増強されたタンパク質発現 |
DE602005023138D1 (de) | 2004-04-15 | 2010-10-07 | Genencor Int | Anti-cea scfv-beta-lactamase konstrukte (cab moleküle) in adept |
EP1740952A2 (en) * | 2004-04-26 | 2007-01-10 | Genencor International, Inc. | Population based prediction methods for immune response determinations and methods for verifying immunological response data |
US8298824B2 (en) | 2004-04-28 | 2012-10-30 | Sanofi Pasteur Vaxdesign Corporation | Methods of evaluating a test agent in a diseased cell model |
US7709256B2 (en) * | 2004-04-28 | 2010-05-04 | Vaxdesign Corp. | Disease model incorporation into an artificial immune system (AIS) |
US20070141552A1 (en) * | 2004-04-28 | 2007-06-21 | Warren William L | Automatable artificial immune system (AIS) |
US7785806B2 (en) * | 2004-04-28 | 2010-08-31 | Vaxdesign Corporation | Method for determining the immunogenicity of an antigen |
US7771999B2 (en) * | 2004-04-28 | 2010-08-10 | Vaxdesign Corp. | Disease model incorporation into an artificial immune system (AIS) |
US20060275270A1 (en) * | 2004-04-28 | 2006-12-07 | Warren William L | In vitro mucosal tissue equivalent |
US7855074B2 (en) * | 2004-04-28 | 2010-12-21 | Vaxdesign Corp. | Artificial immune system: methods for making and use |
CA2564512C (en) | 2004-04-28 | 2014-03-18 | Vaxdesign Corporation | Artificial immune system: methods for making and use |
US7785883B2 (en) * | 2004-04-28 | 2010-08-31 | Vax Design Corp. | Automatable artificial immune system (AIS) |
US8030070B2 (en) * | 2004-04-28 | 2011-10-04 | Sanofi Pasteur Vaxdesign Corp. | Artificial lymphoid tissue equivalent |
US8071373B2 (en) | 2004-04-28 | 2011-12-06 | Sanofi Pasteur Vaxdesign Corp. | Co-culture lymphoid tissue equivalent (LTE) for an artificial immune system (AIS) |
US20090060933A1 (en) * | 2004-06-14 | 2009-03-05 | Estell David A | Proteases producing an altered immunogenic response and methods of making and using the same |
MXPA06014649A (es) | 2004-06-21 | 2007-03-12 | Novozymes As | Proteasas. |
AU2006210724A1 (en) * | 2005-02-03 | 2006-08-10 | Antitope Limited | Human antibodies and proteins |
JP5153613B2 (ja) * | 2005-03-18 | 2013-02-27 | メディミューン,エルエルシー | 抗体のフレームワーク・シャッフル |
AU2006236905B2 (en) * | 2005-04-15 | 2010-06-03 | The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Methods and compositions for producing an enhanced immune response to a human papillomavirus immunogen |
EP1904531B1 (en) * | 2005-07-08 | 2010-10-06 | Pfizer Limited | Madcam antibodies |
EP1919951B1 (en) * | 2005-08-04 | 2015-01-28 | Janssen Biotech, Inc. | Anti-tnf-alpha antibodies and methods of use |
WO2007031741A1 (en) * | 2005-09-14 | 2007-03-22 | Cambridge Antibody Technology Limited | Pseudomonas exotoxin a cd4+ t-cell epitopes |
EP1969366B1 (en) * | 2005-12-21 | 2015-10-21 | Sanofi Pasteur VaxDesign Corporation | In vitro germinal centers |
ATE495238T1 (de) * | 2005-12-21 | 2011-01-15 | Vaxdesign Corp | Iin vitro methode um eine potentielle reaktion eines tieres an einen agenten zu bestimmen |
EP2351830B1 (en) | 2006-03-23 | 2014-04-23 | Ajinomoto Co., Inc. | A method for producing an L-amino acid using bacterium of the Enterobacteriaceae family with attenuated expression of a gene coding for small RNA |
EP2409714A1 (en) * | 2006-06-27 | 2012-01-25 | Sanofi Pasteur VaxDesign Corporation | Models for vaccine assessment |
KR20090088852A (ko) | 2006-09-05 | 2009-08-20 | 메다렉스, 인코포레이티드 | 골형성 단백질의 항체와 이의 수용체 및 이의 사용방법 |
US20080090745A1 (en) * | 2006-10-13 | 2008-04-17 | Fox Bryan P | Expression of Streptomyces subtilism inhibitor (SSI) proteins in Bacillus and Streptomyces sp. |
JP2010507001A (ja) * | 2006-10-16 | 2010-03-04 | ダニスコ・ユーエス・インク、ジェネンコー・ディビジョン | 非リン酸系食器洗浄剤 |
MX2009006277A (es) | 2006-12-14 | 2009-07-24 | Medarex Inc | Anticuerpos humanos que se enlazan a cd70 y usos de los mismos. |
RU2496875C2 (ru) | 2007-03-12 | 2013-10-27 | ДАНИСКО ЮЭс ИНК. | Мoдифицированные протеазы |
ATE550348T1 (de) | 2007-05-10 | 2012-04-15 | Danisco Us Inc | Modifiziertes ausscheidungssystem zur erhöhung der expression von polypeptiden in bakterien |
JP2010530895A (ja) | 2007-06-21 | 2010-09-16 | アンジェリカ セラピューティックス,インク. | 修飾毒素 |
WO2009048661A1 (en) | 2007-07-16 | 2009-04-16 | Vaxdesign Corporation | Artificial tissue constructs comprising alveolar cells and methods for using the same |
KR20100098652A (ko) | 2007-12-21 | 2010-09-08 | 다니스코 유에스 인크. | 바실루스 내에서의 향상된 단백질 생산 |
CA2717197C (en) * | 2008-03-12 | 2016-12-20 | Vaxdesign Corporation | Disease model incorporation into an artificial immune system (ais) |
DK2257629T3 (da) * | 2008-03-28 | 2016-06-13 | Danisco Us Inc | Fremgangsmåde til locusamplifikation i en bakteriecelle |
CN102245635B (zh) | 2008-10-15 | 2016-08-31 | 丹尼斯科美国公司 | 修饰的变体bowman birk蛋白酶抑制剂 |
US7772181B2 (en) | 2008-10-15 | 2010-08-10 | Danisco Us Inc. | Personal care compositions comprising modified variant Bowman Birk Protease Inhibitors |
US7803902B2 (en) | 2008-10-15 | 2010-09-28 | Danisco Us Inc. | Modified variant bowman birk protease inhibitors |
RU2560978C2 (ru) | 2008-11-11 | 2015-08-20 | ДАНИСКО ЮЭс ИНК. | Протеазы, содержащие одну или несколько комбинируемых мутаций |
EP2647692A3 (en) * | 2008-11-11 | 2014-01-22 | The Procter and Gamble Company | Compositions and methods comprising serine protease variants |
FR2940451B1 (fr) | 2008-12-18 | 2014-09-12 | Proteus | Procede d'evaluation de l'immunogenicite des proteines |
AR076941A1 (es) | 2009-06-11 | 2011-07-20 | Danisco Us Inc | Cepa de bacillus para una mayor produccion de proteina |
BR112012006497A2 (pt) * | 2009-09-25 | 2015-09-08 | Novozymes As | uso de uma variante de subtilisina, composição de lavagem de pratos, e, uso de uma composição. |
EP2510092A1 (en) * | 2009-12-09 | 2012-10-17 | The Procter & Gamble Company | Fabric and home care products |
CA2902905A1 (en) | 2013-03-15 | 2014-09-25 | Claude Geoffrey Davis | Modified toxins |
US10287591B2 (en) | 2013-12-31 | 2019-05-14 | Danisco Us Inc | Enhanced protein expression |
CA2943569C (en) | 2014-03-27 | 2021-02-23 | British Columbia Cancer Agency Branch | T-cell epitope identification |
US10683528B2 (en) | 2014-12-16 | 2020-06-16 | Danisco Us Inc | Enhanced protein expression |
KR20170093247A (ko) | 2014-12-19 | 2017-08-14 | 다니스코 유에스 인크. | 향상된 단백질 발현 |
GB201501565D0 (en) * | 2015-01-30 | 2015-03-18 | Dupont Nutrition Biosci Aps | Method |
US11866713B2 (en) | 2017-02-24 | 2024-01-09 | Danisco Us Inc. | Compositions and methods for increased protein production in bacillus licheniformis |
EP3655537A1 (en) | 2017-08-23 | 2020-05-27 | Danisco US Inc. | Methods and compositions for efficient genetic modifications of bacillus licheniformis strains |
CN111094576A (zh) | 2017-09-13 | 2020-05-01 | 丹尼斯科美国公司 | 用于增加芽胞杆菌属中蛋白质产生的经修饰的5′-非翻译区(utr)序列 |
WO2019089898A1 (en) | 2017-11-02 | 2019-05-09 | Danisco Us Inc | Freezing point depressed solid matrix compositions for melt granulation of enzymes |
KR20200105879A (ko) | 2018-01-03 | 2020-09-09 | 다니스코 유에스 인크. | 증가된 단백질 생산을 위한 돌연변이체 및 유전자 변형된 바실러스 세포 및 이의 방법 |
JP2023524334A (ja) | 2020-01-15 | 2023-06-12 | ダニスコ・ユーエス・インク | バチルス・リケニフォルミス(bacillus licheniformis)における強化したタンパク質産生のための組成物及び方法 |
WO2023023644A1 (en) | 2021-08-20 | 2023-02-23 | Danisco Us Inc. | Polynucleotides encoding novel nucleases, compositions thereof and methods thereof for eliminating dna from protein preparations |
Family Cites Families (42)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5913187B2 (ja) | 1978-07-04 | 1984-03-28 | ノヴオ インダストリ エ−/エス | プロテア−ゼ濃縮物 |
US4261868A (en) | 1979-08-08 | 1981-04-14 | Lever Brothers Company | Stabilized enzymatic liquid detergent composition containing a polyalkanolamine and a boron compound |
US4404128A (en) | 1981-05-29 | 1983-09-13 | The Procter & Gamble Company | Enzyme detergent composition |
JPS58144105A (ja) | 1982-02-12 | 1983-08-27 | Kurabo Ind Ltd | スケ−ル除去獣毛繊維の製法 |
US4760025A (en) | 1984-05-29 | 1988-07-26 | Genencor, Inc. | Modified enzymes and methods for making same |
US5204015A (en) | 1984-05-29 | 1993-04-20 | Genencor International, Inc. | Subtilisin mutants |
US5801038A (en) * | 1984-05-29 | 1998-09-01 | Genencor International Inc. | Modified subtilisins having amino acid alterations |
US5185258A (en) | 1984-05-29 | 1993-02-09 | Genencor International, Inc. | Subtilisin mutants |
US5264366A (en) | 1984-05-29 | 1993-11-23 | Genencor, Inc. | Protease deficient bacillus |
US5182204A (en) | 1984-05-29 | 1993-01-26 | Genencor International, Inc. | Non-human carbonyl hydrolase mutants, vectors encoding same and hosts transformed with said vectors |
IE65767B1 (en) * | 1986-04-30 | 1995-11-15 | Genencor Int | Non-human carbonyl hydrolase mutants DNA sequences and vectors encoding same and hosts transformed with said vectors |
US5314692A (en) | 1987-08-24 | 1994-05-24 | Cultor Ltd. | Enzyme premix for feed and method |
EP0344259A4 (en) | 1987-10-30 | 1991-04-24 | Lsi Logic Corporation | Method and means of fabricating a semiconductor device package |
DK6488D0 (da) | 1988-01-07 | 1988-01-07 | Novo Industri As | Enzymer |
US4874070A (en) | 1988-02-10 | 1989-10-17 | Eaton Corporation | Control for AMT system start from stop operation |
DE3841152A1 (de) | 1988-12-07 | 1990-06-13 | Hoechst Ag | Verwendung von bakterienlysierendem enzymprodukt als zusatzstoff zur verbesserung der futterverwertung in der tierproduktion |
CA2331936C (en) | 1990-12-05 | 2007-07-31 | Novozymes A/S | Proteins with changed epitopes and methods for the production thereof |
US5766898A (en) * | 1990-12-05 | 1998-06-16 | Novo Nordisk A/S | Proteins with changed epitopes and methods for the production thereof |
ATE260971T1 (de) * | 1992-04-01 | 2004-03-15 | Univ Rockefeller | Verfahren zur in vitro kultivierung dendritischer vorläuferzellen und deren verwendung zur immunogen herstellung |
AU4678993A (en) * | 1992-07-16 | 1994-02-14 | Board Of Trustees Of The Leland Stanford Junior University | Methods for using dendritic cells to activate t cells |
DK132892D0 (da) | 1992-10-30 | 1992-10-30 | Novo Nordisk As | Proteiner |
US5593877A (en) * | 1993-03-11 | 1997-01-14 | The Rockefeller University | Nucleic acid and recombinant production of vespid venom hyaluronidase |
US5585250A (en) * | 1993-08-20 | 1996-12-17 | The United States Of America As Represented By The Department Of Health & Human Services | Dampening of an immunodominant epitope of an antigen for use in plant, animal and human compositions and immunotherapies |
US5820862A (en) * | 1994-04-14 | 1998-10-13 | Immulogic Pharmaceutical Corporation | T cell epitopes of the major allergens from dermatophagoides (house dust mite) |
CU22615A1 (es) | 1994-06-30 | 2000-02-10 | Centro Inmunologia Molecular | Procedimiento de obtención de anticuerpos monoclonales murinos menos inmunogénicos. anticuerpos monoclonales obtenidos |
GB9416841D0 (en) | 1994-08-19 | 1994-10-12 | Finnfeeds Int Ltd | An enzyme feed additive and animal feed including it |
US5648219A (en) * | 1995-06-07 | 1997-07-15 | Zymogenetics, Inc. | Immortalized dendritic cells |
WO1996016177A1 (en) | 1994-11-24 | 1996-05-30 | Novo Nordisk A/S | A process for producing polypeptides with reduced allergenicity |
US5856451A (en) | 1994-12-07 | 1999-01-05 | Novo Nordisk A/S | Method for reducing respiratory allergenicity |
US5951980A (en) * | 1995-01-06 | 1999-09-14 | Leuven Research & Development Vzw | Identification, production and use of new staphylokinase derivatives with reduced immunogenicity |
ATE429490T1 (de) | 1995-05-05 | 2009-05-15 | Novozymes As | Protease-varianten und verbindungen |
US5837517A (en) * | 1995-05-05 | 1998-11-17 | Novo Nordisk A/S | Protease variants and compositions |
AU5893696A (en) | 1995-06-07 | 1996-12-30 | Novo Nordisk A/S | Modification of polypeptides |
JP2000506119A (ja) | 1996-02-15 | 2000-05-23 | ノボ ノルディスク アクティーゼルスカブ | ポリペプチドのコンジュゲーション |
US5849589A (en) * | 1996-03-11 | 1998-12-15 | Duke University | Culturing monocytes with IL-4, TNF-α and GM-CSF TO induce differentiation to dendric cells |
CN1136311C (zh) | 1996-11-04 | 2004-01-28 | 诺沃奇梅兹有限公司 | 枯草杆菌酶变异体和组合物 |
EP1724282B1 (en) | 1997-05-21 | 2013-05-15 | Merck Patent GmbH | Method for the production of non-immunogenic proteins |
US6495136B1 (en) * | 1998-03-26 | 2002-12-17 | The Procter & Gamble Company | Proteases having modified amino acid sequences conjugated to addition moieties |
US6835550B1 (en) | 1998-04-15 | 2004-12-28 | Genencor International, Inc. | Mutant proteins having lower allergenic response in humans and methods for constructing, identifying and producing such proteins |
CA2238660A1 (en) | 1998-05-22 | 1999-11-22 | Janet Chantler | Gene sequences of rubella virus associated with attenuation |
ES2220114T3 (es) * | 1998-10-30 | 2004-12-01 | Novozymes A/S | Variantes de proteinas poco alergenicas. |
GB9913425D0 (en) * | 1999-06-09 | 1999-08-11 | Universitu Libre De Bruxelles | Identification and molecular characterisation of proteins expressed in the tick salivary glands |
-
1998
- 1998-04-15 US US09/060,872 patent/US6835550B1/en not_active Expired - Lifetime
-
1999
- 1999-02-23 US US09/255,502 patent/US6218165B1/en not_active Expired - Lifetime
- 1999-02-23 US US09/255,501 patent/US6596525B1/en not_active Expired - Lifetime
- 1999-04-14 ID IDW20002059A patent/ID26645A/id unknown
- 1999-04-14 IL IL13844599A patent/IL138445A0/xx unknown
- 1999-04-14 CZ CZ20003789A patent/CZ20003789A3/cs unknown
- 1999-04-14 NZ NZ524596A patent/NZ524596A/en not_active IP Right Cessation
- 1999-04-14 EP EP08009499A patent/EP1997897B1/en not_active Revoked
- 1999-04-14 DK DK99918575T patent/DK1073754T3/da active
- 1999-04-14 AT AT04016880T patent/ATE452195T1/de not_active IP Right Cessation
- 1999-04-14 KR KR1020007011376A patent/KR20010034776A/ko not_active Application Discontinuation
- 1999-04-14 DE DE69941827T patent/DE69941827D1/de not_active Expired - Lifetime
- 1999-04-14 NZ NZ506926A patent/NZ506926A/en not_active IP Right Cessation
- 1999-04-14 CA CA2327311A patent/CA2327311C/en not_active Expired - Fee Related
- 1999-04-14 CN CNB998050547A patent/CN1302113C/zh not_active Expired - Fee Related
- 1999-04-14 MX MXPA05003288A patent/MXPA05003288A/es active IP Right Grant
- 1999-04-14 BR BR9909640-4A patent/BR9909640A/pt not_active Application Discontinuation
- 1999-04-14 AT AT99918575T patent/ATE277189T1/de not_active IP Right Cessation
- 1999-04-14 DK DK08009499.8T patent/DK1997897T3/da active
- 1999-04-14 AU AU36454/99A patent/AU752934B2/en not_active Ceased
- 1999-04-14 WO PCT/US1999/008253 patent/WO1999053038A2/en active Application Filing
- 1999-04-14 EP EP04016880A patent/EP1586649B1/en not_active Expired - Lifetime
- 1999-04-14 DE DE69920434T patent/DE69920434T4/de not_active Expired - Lifetime
- 1999-04-14 DE DE69920434A patent/DE69920434D1/de not_active Expired - Lifetime
- 1999-04-14 PL PL99343509A patent/PL343509A1/xx unknown
- 1999-04-14 ES ES99918575T patent/ES2229703T4/es not_active Expired - Lifetime
- 1999-04-14 EP EP99918575A patent/EP1073754B9/en not_active Revoked
- 1999-04-14 DK DK04016880.9T patent/DK1586649T3/da active
- 1999-04-14 ES ES04016880T patent/ES2338319T3/es not_active Expired - Lifetime
- 1999-04-14 MX MXPA05003289A patent/MXPA05003289A/es active IP Right Grant
- 1999-04-14 JP JP2000543586A patent/JP4447774B2/ja not_active Expired - Fee Related
-
2000
- 2000-09-13 IL IL138445A patent/IL138445A/en not_active IP Right Cessation
- 2000-10-13 NO NO20005153A patent/NO20005153L/no not_active Application Discontinuation
-
2004
- 2004-08-23 US US10/924,092 patent/US20050137112A1/en not_active Abandoned
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1073754T3 (da) | Fremgangsmåde til fremstilling af proteinmutanter med lille allergen reaktion hos mennesker | |
DE69938302D1 (de) | Neisseria meningitidis antigene und zusammenstellungen | |
NO994998D0 (no) | Fusjonsproteiner | |
DE69941567D1 (de) | Antigene aus neisseria meningitidis | |
DK1135498T3 (da) | Antistofvarianter med höjere bindingsaffinitet end forældreantistoffer | |
DK1071792T3 (da) | Human protease og anvendelse af en sådan protease til farmaceutiske anvendelser og til reducering af allergeniciteten af ikke-humane proteiner | |
DE69820895D1 (de) | Verfahren und reagens fur n-alkylierte ureide | |
ATE413412T1 (de) | Immunmodulierende wirkstoffe aus parasitären würmern und verfahren zu deren isolierung | |
Larichev | The Great Code of Laws of the Vault of Heaven as It Is Depicted on the Bronze Mirror | |
ES1034462Y (es) | Nucleo de muelles para la fabricacion de cojines. | |
ATE455794T1 (de) | Monoklonale antikörper gegen humane thymidylat- synthase und hybridomen zu derer herstellung |